1. Home
  2. BCAR vs TMCI Comparison

BCAR vs TMCI Comparison

Compare BCAR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAR
  • TMCI
  • Stock Information
  • Founded
  • BCAR 2025
  • TMCI 2014
  • Country
  • BCAR United States
  • TMCI United States
  • Employees
  • BCAR N/A
  • TMCI N/A
  • Industry
  • BCAR Blank Checks
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BCAR Finance
  • TMCI Health Care
  • Exchange
  • BCAR Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • BCAR 419.8M
  • TMCI 449.2M
  • IPO Year
  • BCAR 2025
  • TMCI 2021
  • Fundamental
  • Price
  • BCAR $9.95
  • TMCI $6.36
  • Analyst Decision
  • BCAR
  • TMCI Hold
  • Analyst Count
  • BCAR 0
  • TMCI 5
  • Target Price
  • BCAR N/A
  • TMCI $8.60
  • AVG Volume (30 Days)
  • BCAR 172.6K
  • TMCI 313.1K
  • Earning Date
  • BCAR 01-01-0001
  • TMCI 11-04-2025
  • Dividend Yield
  • BCAR N/A
  • TMCI N/A
  • EPS Growth
  • BCAR N/A
  • TMCI N/A
  • EPS
  • BCAR N/A
  • TMCI N/A
  • Revenue
  • BCAR N/A
  • TMCI $213,751,000.00
  • Revenue This Year
  • BCAR N/A
  • TMCI $10.63
  • Revenue Next Year
  • BCAR N/A
  • TMCI $9.43
  • P/E Ratio
  • BCAR N/A
  • TMCI N/A
  • Revenue Growth
  • BCAR N/A
  • TMCI 7.67
  • 52 Week Low
  • BCAR $9.88
  • TMCI $4.54
  • 52 Week High
  • BCAR $9.96
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • BCAR N/A
  • TMCI 37.15
  • Support Level
  • BCAR N/A
  • TMCI $6.55
  • Resistance Level
  • BCAR N/A
  • TMCI $7.10
  • Average True Range (ATR)
  • BCAR 0.00
  • TMCI 0.33
  • MACD
  • BCAR 0.00
  • TMCI -0.10
  • Stochastic Oscillator
  • BCAR 0.00
  • TMCI 18.06

About BCAR D. Boral ARC Acquisition I Corp. Class A Ordinary Shares

D Boral ARC Acquisition I Corp is a blank check company.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: